Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-140265
Filing Date
2011-05-16
Accepted
2011-05-16 06:12:37
Documents
6
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 234175
2 LICENSE AGREEMENT DATED JULY 2007 dex101.htm EX-10.1 188120
3 SECTION 302 CEO AND CFO CERTIFICATION dex31.htm EX-31 7942
4 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 3949
5 GRAPHIC g186733g55b97.jpg GRAPHIC 10398
6 GRAPHIC g186733g65c47.jpg GRAPHIC 9217
  Complete submission text file 0001193125-11-140265.txt   462642
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 (617) 475-1520
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-52089 | Film No.: 11843286
SIC: 3841 Surgical & Medical Instruments & Apparatus